Comparison of effectiveness and safety of microwave ablation of colorectal liver metastases adjacent versus nonadjacent to the diaphragm Journal Article


Authors: Dimopoulos, M. P.; Sotirchos, V. S.; Dunnejaffe, C.; Petre, E. N.; Moussa, A.; Soares, K.; Solomon, S. B.; Sofocleous, C. T.
Article Title: Comparison of effectiveness and safety of microwave ablation of colorectal liver metastases adjacent versus nonadjacent to the diaphragm
Abstract: Purpose: To compare the effectiveness and safety of percutaneous microwave ablation (MWA) for colorectal liver metastasis (CLM) adjacent versus nonadjacent to the diaphragm. Materials and Methods: This was a retrospective analysis of a prospectively created MWA database, from 2 prospective clinical trials for patients with CLM treated in a single tertiary center from 2012 to 2023. CLM adjacent to the diaphragm was defined as a tumor located <1 cm from the diaphragm. Minimal ablation margin (MM) was calculated with 3-dimensional software using postablation contrast-enhanced computed tomography (CT). Adverse events were assessed with Common Terminology Criteria for Adverse Events (CTCAE) v5.0 classification for 6 months. Results: Two hundred nine CLMs underwent 191 MWA sessions in 143 patients. Mean tumor diameter was 1.52 cm (SD ± 0.53). Eighty-three of 209 (39.7%) CLMs were adjacent to the diaphragm. There was no difference in local tumor progression–free survival (LTPFS) between CLMs adjacent and nonadjacent to the diaphragm (hazard ratio [HR], 0.65; 95% CI, 0.37–1.16; P = .15). MMs of 5–10 mm and >10 mm were documented in 49.3% versus 46.8% (P = .83) and 21.6% versus 12.6% (P = .16) for CLMs adjacent versus nonadjacent to the diaphragm, respectively. Twelve-month LTPFS was similar between groups (HR, 0.65; 95% CI, 0.37–1.16; P = .15) without local tumor progression for MM of >10 mm. There were 3 Grade IV adverse events: 1 diaphragmatic perforation, 1 liver abscess, and 1 biloma. Pneumothorax was associated with location adjacent to the diaphragm (P < .001) and transpulmonary approach (P < .001). Median length of hospital stay was 2 days (interquartile range [IQR], 1–3 days) for patients who needed thoracostomy (n = 20, 9.6%) compared with 1 day (IQR, 1–8 days) for those who did not, without long-term sequelae. Conclusions: MWA of CLM adjacent to the diaphragm is effective and safe, without difference in success and 12-month LTPFS. Pneumothorax was associated with location adjacent to the diaphragm and thoracostomy that resulted in longer hospitalization without long-term sequelae. © 2024 SIR
Keywords: adult; controlled study; treatment response; middle aged; major clinical study; cancer localization; cancer growth; positron emission tomography; progression free survival; computer assisted tomography; cohort analysis; retrospective study; risk assessment; length of stay; pneumothorax; contrast enhancement; cancer size; observational study; liver abscess; diaphragm; thoracostomy; comparative effectiveness; perforation; biloma; Common Terminology Criteria for Adverse Events; colorectal liver metastasis; human; male; female; article; tertiary care center; diaphragm injury; microwave thermotherapy; tumor margin
Journal Title: Journal of Vascular and Interventional Radiology
Volume: 35
Issue: 12
ISSN: 1051-0443
Publisher: Elsevier Science, Inc.  
Date Published: 2024-12-01
Start Page: 1814
End Page: 1822
Language: English
DOI: 10.1016/j.jvir.2024.08.016
PUBMED: 39187125
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Constantinos T. Sofocleous -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Solomon
    422 Solomon
  2. Elena Nadia Petre
    108 Petre
  3. Amgad Mohamed Abdelhady Moussa
    34 Moussa
  4. Kevin Cerqueira Soares
    136 Soares